{"id":337,"date":"2017-09-15T09:04:55","date_gmt":"2017-09-15T14:04:55","guid":{"rendered":"\/?p=337"},"modified":"2018-02-02T07:53:27","modified_gmt":"2018-02-02T13:53:27","slug":"veterinary-oncology-market-profiled-new-report-brakke-consulting","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","title":{"rendered":"Mercado de oncologia veterin\u00e1ria \u00e9 perfilado em novo relat\u00f3rio da Brakke Consulting"},"content":{"rendered":"

9\/15\/2017<\/em><\/p>\n

Um novo estudo da Brakke Consulting oferece uma vis\u00e3o do assassino #1 de c\u00e3es e gatos: o c\u00e2ncer.<\/p>\n

"A oncologia \u00e9 uma das \u00e1reas de maior interesse na medicina veterin\u00e1ria hoje", disse Lynn Fondon DVM, consultor s\u00eanior da Brakke Consulting. \u201cNa \u00faltima d\u00e9cada, os EUA passaram de zero terapias de c\u00e2ncer aprovadas para uso veterin\u00e1rio para mais de meia d\u00fazia, com dezenas de outras em desenvolvimento.\u201d<\/p>\n

O estudo C\u00e2ncer em C\u00e3es e Gatos fornece informa\u00e7\u00f5es sobre a incid\u00eancia de c\u00e2ncer em animais de estima\u00e7\u00e3o, examina como o c\u00e2ncer \u00e9 diagnosticado e tratado na medicina veterin\u00e1ria e oferece custos estimados para o tratamento. O relat\u00f3rio analisa os tratamentos de c\u00e2ncer aprovados pela FDA que est\u00e3o agora no mercado; produtos veterin\u00e1rios novos e em desenvolvimento, incluindo terapias, diagn\u00f3sticos e cuidados de suporte, tamb\u00e9m s\u00e3o apresentados no relat\u00f3rio. O relat\u00f3rio estima as vendas atuais de terapias contra o c\u00e2ncer aprovadas por veterin\u00e1rios, al\u00e9m de fornecer estimativas do n\u00famero total de animais de estima\u00e7\u00e3o tratados com quimioterapia ou imunoterapia.<\/p>\n

\u201cPesquisamos veterin\u00e1rios e donos de animais para este estudo e descobrimos que, apesar dos custos que podem chegar a milhares de d\u00f3lares, muitos donos de c\u00e3es e gatos est\u00e3o dispostos a buscar tratamento quando seus animais de estima\u00e7\u00e3o s\u00e3o diagnosticados com c\u00e2ncer\u201d, comenta o Dr. Fondon.<\/p>\n

O relat\u00f3rio \u2013 a quarta edi\u00e7\u00e3o de um estudo realizado pela primeira vez em 2002 e posteriormente atualizado em 2009 e 2014 \u2013 reuniu informa\u00e7\u00f5es de uma ampla variedade de fontes, incluindo literatura publicada, entrevistas com especialistas e uma pesquisa com mais de 350 veterin\u00e1rios de pequenos animais e 500 animais de estima\u00e7\u00e3o. os Propriet\u00e1rios.<\/p>\n

O c\u00e2ncer em c\u00e3es e gatos est\u00e1 dispon\u00edvel na Brakke Consulting por $7.500. Para obter mais informa\u00e7\u00f5es, as empresas interessadas podem visitar o site da Brakke Consulting em www.BrakkeConsulting.com.<\/p>\n

Sobre a Brakke Consulting<\/strong><\/p>\n

Por 30 anos, a Brakke Consulting oferece solu\u00e7\u00f5es abrangentes para a ind\u00fastria de sa\u00fade animal, incluindo pesquisa de mercado, desenvolvimento de novos neg\u00f3cios, avalia\u00e7\u00e3o de produtos e estrat\u00e9gias de distribui\u00e7\u00e3o. A empresa \u00e9 conhecida por seus estudos de mercado sindicalizados, fornecendo informa\u00e7\u00f5es estrat\u00e9gicas e oportunas para o setor.<\/p>\n

###<\/p>\n

compat\u00edvel com impressora<\/a><\/p>","protected":false},"excerpt":{"rendered":"

15\/09\/2017 Um novo estudo da Brakke Consulting oferece uma vis\u00e3o sobre o assassino #1 de c\u00e3es e gatos: o c\u00e2ncer. \u201cA oncologia \u00e9 uma das \u00e1reas de maior interesse na medicina veterin\u00e1ria atualmente\u201d, disse Lynn Fondon DVM, consultora s\u00eanior da Brakke Consulting. \u201cNa \u00faltima d\u00e9cada, os EUA passaram de zero terapias contra o c\u00e2ncer aprovadas para uso veterin\u00e1rio para mais de meia d\u00fazia, com dezenas de outras em desenvolvimento\u201d. O estudo, C\u00e2ncer em C\u00e3es e Gatos, fornece informa\u00e7\u00f5es sobre a incid\u00eancia de c\u00e2ncer em animais de estima\u00e7\u00e3o, examina como o c\u00e2ncer \u00e9 diagnosticado e tratado na medicina veterin\u00e1ria e oferece custos estimados para o tratamento. O relat\u00f3rio analisa os tratamentos contra o c\u00e2ncer aprovados pela FDA que est\u00e3o agora no mercado; produtos veterin\u00e1rios novos e em desenvolvimento contra o c\u00e2ncer, incluindo terapias, diagn\u00f3sticos e cuidados de suporte, tamb\u00e9m s\u00e3o apresentados no relat\u00f3rio. O relat\u00f3rio estima as vendas atuais de terapias contra o c\u00e2ncer aprovadas por veterin\u00e1rios, al\u00e9m de fornecer estimativas do n\u00famero total de animais de estima\u00e7\u00e3o tratados com quimioterapia ou imunoterapia. \u201cPara este estudo, entrevistamos veterin\u00e1rios e donos de animais de estima\u00e7\u00e3o e descobrimos que, apesar dos custos que podem chegar a milhares de d\u00f3lares, muitos donos de c\u00e3es e gatos est\u00e3o dispostos a buscar tratamento quando seus animais de estima\u00e7\u00e3o s\u00e3o diagnosticados com c\u00e2ncer\u201d, comenta o Dr. O relat\u00f3rio \u2013 a quarta edi\u00e7\u00e3o de um estudo realizado pela primeira vez em 2002 e posteriormente atualizado em 2009 e 2014 \u2013<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"class_list":["post-337","post","type-post","status-publish","format-standard","hentry","category-company-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"9\/15\/2017 A new study from Brakke Consulting offers a look into the #1 killer of dogs and cats: cancer. \u201dOncology is one of the highest interest areas in veterinary medicine today,\u201d said Lynn Fondon DVM, a senior consultant at Brakke Consulting. \u201cIn the past decade, the US has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development.\u201d The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented in the report. The report estimates the current sales of veterinary-approved cancer therapies, as well as providing estimates of the total number of pets treated with chemotherapy or immunotherapy. \u201cWe surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,\u201d comments Dr. Fondon. The report – the fourth edition of a study first fielded in 2002, and subsequently updated in 2009 and 2014 –View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-15T14:04:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-02T13:53:27+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Veterinary oncology market is profiled in new report from Brakke Consulting\",\"datePublished\":\"2017-09-15T14:04:55+00:00\",\"dateModified\":\"2018-02-02T13:53:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\"},\"wordCount\":321,\"articleSection\":[\"Company News\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\",\"url\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2017-09-15T14:04:55+00:00\",\"dateModified\":\"2018-02-02T13:53:27+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Veterinary oncology market is profiled in new report from Brakke Consulting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"9\/15\/2017 A new study from Brakke Consulting offers a look into the #1 killer of dogs and cats: cancer. \u201dOncology is one of the highest interest areas in veterinary medicine today,\u201d said Lynn Fondon DVM, a senior consultant at Brakke Consulting. \u201cIn the past decade, the US has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development.\u201d The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented in the report. The report estimates the current sales of veterinary-approved cancer therapies, as well as providing estimates of the total number of pets treated with chemotherapy or immunotherapy. \u201cWe surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,\u201d comments Dr. Fondon. The report – the fourth edition of a study first fielded in 2002, and subsequently updated in 2009 and 2014 –View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","og_site_name":"Brakke Consulting Website","article_published_time":"2017-09-15T14:04:55+00:00","article_modified_time":"2018-02-02T13:53:27+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Veterinary oncology market is profiled in new report from Brakke Consulting","datePublished":"2017-09-15T14:04:55+00:00","dateModified":"2018-02-02T13:53:27+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/"},"wordCount":321,"articleSection":["Company News"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","url":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2017-09-15T14:04:55+00:00","dateModified":"2018-02-02T13:53:27+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/veterinary-oncology-market-profiled-new-report-brakke-consulting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Veterinary oncology market is profiled in new report from Brakke Consulting"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=337"}],"version-history":[{"count":2,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/337\/revisions"}],"predecessor-version":[{"id":11989,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/337\/revisions\/11989"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}